Apellis Pharmaceuticals, Inc. - Common Stock (APLS)

394 filings reported holding APLS - Apellis Pharmaceuticals, Inc. - Common Stock as of Q1 2024.
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) has 296 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 113,103,917 shares of 127,672,444 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (15,058,071 shares), EcoR1 Capital, LLC (11,357,425 shares), Avoro Capital Advisors LLC (11,111,111 shares), VANGUARD GROUP INC (9,505,866 shares), BlackRock Inc. (5,494,591 shares), T. Rowe Price Investment Management, Inc. (4,605,721 shares), JENNISON ASSOCIATES LLC (3,240,513 shares), STATE STREET CORP (2,909,528 shares), Octagon Capital Advisors LP (2,806,980 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2,459,246 shares).
This table shows the top 296 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.